Health Library › Conditions › Solitary pulmonary nodule
Condition
A solitary pulmonary nodule is a single small, rounded spot found in the lung on imaging.
A solitary pulmonary nodule is a single, rounded spot seen within the lung on an X-ray or computed tomography scan, usually called a CT scan. It is an imaging finding rather than a disease by itself.
Pulmonary means related to the lungs. A nodule is usually no more than 3 centimetres across. A larger abnormal area is called a lung mass and is assessed differently.
Most nodules are discovered by chance during imaging for another reason, such as an injury, infection, heart problem, or health screening. Many are scars or signs of an old infection. Some are slow-growing, non-cancerous growths. A smaller number are an early lung cancer or cancer that has spread from another part of the body.
Finding a nodule does not mean that you have cancer. Its importance depends on details such as its size, appearance, growth over time, and whether you have risk factors for lung cancer. Reviewing older scans is often one of the most useful steps.
A nodule may be described as solid, ground-glass, or part-solid. A ground-glass nodule looks hazy on CT but does not completely hide the lung structures beneath it. A part-solid nodule contains both hazy and solid areas. These types can behave differently and may require different follow-up periods.
A solitary pulmonary nodule usually causes no symptoms. Small nodules generally do not interfere with breathing, and most are found before the person knows they are present.
If symptoms occur, they are more likely to come from the condition that caused the nodule than from the nodule itself. Possible symptoms include:
These symptoms have many possible causes. Having one does not show that a nodule is cancerous. New or persistent symptoms should still be discussed with a healthcare professional rather than waiting for a planned surveillance scan.
A solitary pulmonary nodule can have several causes.
Previous infections can leave a small area of inflammation or scarring. A granuloma is a compact collection of immune cells formed when the body contains an infection or another source of irritation. Granulomas may remain visible long after the original illness has resolved. Certain fungal infections and tuberculosis can cause them.
Non-infectious inflammatory conditions can also produce lung nodules. Examples include rheumatoid arthritis and sarcoidosis, a condition that causes clusters of inflammatory cells in different organs.
A hamartoma is a non-cancerous lung growth made from tissues such as cartilage, fat, and connective tissue. Its appearance on CT may strongly suggest that it is benign.
Some solitary nodules are lung cancer. Less commonly, a nodule may be cancer that has spread to the lung from another organ. Features associated with a greater chance of cancer include:
No single feature proves that a nodule is cancer. People who have never smoked can develop lung cancer, while people with several risk factors may still have a benign nodule.
The first step is usually to review why the imaging was performed and whether older chest images are available. A nodule that has not changed over an appropriate period is less concerning than one that is new or growing. The required comparison period may be longer for ground-glass and part-solid nodules because they can change slowly.
If a nodule was first seen on an X-ray, a chest CT usually provides a clearer view. Thin-section CT images help show:
The clinician may estimate the chance of cancer using the scan findings and factors such as age, smoking history, and previous cancer. Formal risk calculators are sometimes used, but they do not give a definite diagnosis.
Positron emission tomography combined with CT, known as PET-CT, may help assess certain larger or more concerning nodules. It shows areas using increased amounts of a radioactive form of sugar. Cancer may cause increased uptake, but infection and inflammation can do so as well. Very small or slow-growing cancers may not show strong uptake.
A sample of tissue may be needed when imaging cannot give enough certainty and the result would change treatment. Depending on the nodule's location, tissue may be collected through:
A biopsy can identify cancer, infection, or another condition. However, it may not collect enough tissue to provide an answer. Because biopsies have risks, not every nodule needs one.
Nodules found during formal lung cancer screening are assessed using a specific screening system. Recommendations for these nodules may differ from those for nodules found by chance.
Management is based on the estimated chance of cancer and on your general health and preferences. The nodule's size, type, appearance, and growth pattern all matter.
A very small nodule with reassuring features may need no further testing. Others are monitored with one or more low-dose CT scans. Surveillance checks whether the nodule remains stable without exposing you to the risks of an invasive procedure. The timing and length of monitoring are not the same for every nodule.
If the chance of cancer is in an intermediate range, PET-CT, biopsy, or further CT monitoring may be considered. The choice takes account of whether a test is likely to provide a useful answer and whether you could safely undergo treatment if cancer were found.
A nodule with a high chance of cancer may be removed surgically when the person is well enough for an operation. The tissue is examined in a laboratory to determine exactly what it is. If lung cancer is confirmed, treatment depends on its type and stage, meaning how far it has grown or spread.
For an early lung cancer, options may include surgery or focused radiation treatment. Other cancer treatments may be needed if testing shows more extensive disease. Decisions are usually made with input from specialists in lung medicine, radiology, surgery, oncology, and pathology.
If the nodule is caused by an active infection or inflammatory condition, treatment is directed at that cause. A healed scar or calcified granuloma often needs no treatment.
Most solitary pulmonary nodules do not cause physical complications. The main concern is whether a nodule could be cancerous and, if so, whether it might grow while assessment is incomplete.
Follow-up testing also has possible harms. Repeated CT scans involve low levels of radiation. PET-CT can produce unclear or falsely concerning findings when inflammation is present.
A needle biopsy can cause bleeding or a pneumothorax, which means air has leaked around the lung and caused it to partly collapse. Bronchoscopy and surgery have their own risks, including bleeding, infection, and reactions to sedation or anaesthesia. Your healthcare team should explain these risks before a procedure.
Uncertainty can also cause significant worry. Asking for a written follow-up plan may make the waiting period easier to manage.
A solitary pulmonary nodule itself cannot always be prevented. Many result from past infections, inflammation, or scarring that could not have been predicted. There is no proven way to prevent all benign lung nodules.
Avoiding tobacco smoke reduces the risk of lung cancer and other lung diseases. If you smoke, support such as counselling and stop-smoking medicines can improve the chance of quitting.
Reducing exposure to radon and following workplace protections around asbestos, silica, diesel exhaust, and other harmful substances may also lower lung cancer risk. These steps cannot guarantee that a nodule will not develop.
Lung cancer screening is not a way to prevent nodules. It is intended to find possible cancer earlier in people who meet specific age and smoking-history criteria.
Many people continue their usual activities while a nodule is being monitored. The nodule itself commonly causes no limitations and does not require changes to exercise, work, travel, or diet.
The main task is keeping track of follow-up. Ask when the next scan is due, who will review it, and how you will receive the result. Make sure the imaging service has access to older scans, including scans performed at another hospital.
A solid nodule that stays unchanged throughout the recommended monitoring period is often considered benign, and follow-up may then stop. Ground-glass and part-solid nodules may need monitoring for longer because some grow slowly.
Some nodules shrink or disappear, especially when they are related to short-term infection or inflammation. Others remain unchanged for years. Growth does not automatically mean cancer, but it usually leads to further assessment.
If cancer is found while it is still confined to a small nodule, treatment may be possible with the aim of cure. The outlook cannot be predicted from the word “nodule” alone. It is shaped by the tissue diagnosis, cancer stage, overall health, and response to treatment.
Waiting for repeat imaging can be stressful. It may help to write down the nodule's size, type, and planned review date rather than relying on memory. Contact the healthcare team if the plan is unclear or an expected appointment has not arrived.
Arrange routine follow-up if you have been told that a nodule needs another scan, PET-CT, specialist review, or biopsy. Contact the clinic if the planned date passes without an appointment. Delayed paperwork is not usually an emergency, but the follow-up should not be abandoned.
Seek prompt medical advice if you develop:
Call emergency services for severe difficulty breathing, fainting, blue or grey lips, severe chest pain, or coughing up more than small streaks of blood. Sudden breathlessness or sharp chest pain after a lung biopsy also needs emergency assessment because it may indicate a pneumothorax.
Does a solitary pulmonary nodule mean cancer?
No. Many nodules are scars, healed infections, or benign growths. The chance of cancer is assessed from the nodule's size, appearance, growth, and your personal risk factors. Imaging alone can sometimes show a clearly benign cause, while other nodules need monitoring or biopsy.
What size lung nodule is worrying?
Size is important, but there is no single size that proves cancer. Larger nodules generally receive closer assessment, while very small nodules often need limited or no follow-up. Growth, irregular edges, nodule type, smoking history, age, and previous cancer also influence the plan.
Can a lung nodule disappear?
Yes. A nodule caused by temporary infection or inflammation may shrink or disappear. A scar or benign growth may remain unchanged. A disappearing nodule is generally reassuring, but follow-up should continue until the clinician reviewing the scans confirms that it can stop.
How often will I need a CT scan?
The schedule is based on the nodule's size, whether it is solid or subsolid, your cancer risk, and what earlier scans show. Some nodules need no repeat scan. Others need monitoring over months or years. Follow the plan made for your specific imaging findings.
Can a CT scan tell whether the nodule is cancer?
A CT can show features that make cancer more or less likely, but it cannot always give a definite answer. Stability over time can be reassuring. PET-CT may add information in selected cases, while a biopsy or surgical removal provides tissue for a definite laboratory diagnosis.
Should I stop exercising because of a lung nodule?
A small nodule usually does not limit exercise. Unless another lung or heart condition affects you, normal activity is generally possible while it is assessed. Stop and seek medical advice if activity causes new chest pain, marked breathlessness, faintness, or coughing up blood.
sofidex [Internet]. Daloreum; c2026. Solitary pulmonary nodule; [reviewed 2026 Aug 22; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/conditions/solitary-pulmonary-nodule
sofidex. (2026, August 22). Solitary pulmonary nodule. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/conditions/solitary-pulmonary-nodule
Solitary pulmonary nodule. sofidex. Reviewed August 22, 2026. Accessed November 10, 2026. https://sofidex.com/patients/conditions/solitary-pulmonary-nodule
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.